The functional interactions between the endogenous cannabinoid and opioid s
ystems were evaluated in pre-proenkephalin-deficient mice. Antinociception
induced in the tail-immersion test by acute Delta9-tetrahydrocannabinol was
reduced in mutant mice, whereas no difference between genotypes was observ
ed in the effects induced on body temperature, locomotion, or ring cataleps
y. During a chronic treatment with Delta9-tetrahydrocannabinol, the develop
ment of tolerance to the analgesic responses induced by this compound was s
lower in mice lacking enkephalin. In addition, cannabinoid withdrawal syndr
ome, precipitated in Delta9-tetrahydrocannabinol-dependent mice by the inje
ction of SR141716A, was significantly attenuated in mutant mice. These resu
lts indicate that the endogenous enkephalinergic system is involved in the
antinociceptive responses of Delta9-tetrahydrocannabinol and participates i
n the expression of cannabinoid abstinence.